You have successfully logged out.

Hello !
Logout

Central Venous Catheter Certofix®

Your partner for Central Venous Catheters (CVCs) and ECG-guided Tip Positioning

B. Braun offers a comprehensive portfolio of acute central venous catheter sets for both, adult and pediatric patients.
As your system partner for ultrasound-guided central line placement and ECG-guided catheter tip positioning, our goal is to make CVC placement safer

Certofix® Catheter

Safesite® valve

  • Needle-free Injection/Infusion-Valve
  • Allows infusion and blood withdrawal without flow restriction

/

Soft tip

Soft and pliant tip material (PUR)

/

Catheter tubing 

  • with length markings.
  • radiopaque from PUR

/

Mobile Fixation Clips

To adjust optimal skin fixation position with sutured or non-sutured fixation

/

Slide clamps

  • Green: indicate antimicrobial catheter
  • White: indicate non-antimicrobial catheter

/

Catheter hub

Luer-lock connectors

/

  •  from 4,200€ to

    0

    CRBSIs create additional costs per episode ranged

safety scalpel

guidewire

certodyn universal adapter

The following video shows and describes the intraarterial ECG process and the correlation between the catheter position and what is shown on the ECG monitor, in a short and precise way.

Our portfolio at a glance

[1] The Joint Commission. Preventing Central Line–Associated Bloodstream Infections: A Global Challenge, a Global Perspective. Oak Brook, IL: Joint Commission Resources, May 2012. http://www.PreventingCLABSIs.pdf.

[2] https://ecdc.europa.eu/en/publications-data/directory-guidance-prevention-and-control/healthcare-associated-infections-1

[3] Yousif A, Jamal MA, Raad I. Biofilm-based central line-associated bloodstream infections. Adv Exp Med Biol. 2015; 830:157-79

[4] Elliott TSJ. The pathogenesis and prevention of intravascular catheter-related infections. In: Hamilton H, Bodenham AR. Central venous catheters. Chichester [u.a.]: Wiley-Blackwell 2009; 206-209

[5] McLaws ML, Burrell AR. Zero risk for central line-associated bloodstream infection: are we there yet? Crit Care Med. 2012 Feb; 40(2):388-93

[6] Krikava I, et al. The efficacy of a non-leaching antibacterial central venous catheter – a prospective, randomized, double-blind study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Jun;164(2):154-160.

[7] Richards GA, et al. Investigation of biofilm formation on a charged intravenous catheter relative to that on a similar but uncharged catheter

[8] Brunke J, Riemann T, Roschke I, 30 days antimicrobial efficacy of non-leaching central venous catheters (Poster 063), Critical Care 2016, Volume 20 Suppl 2.

[9] Brunke J, et al. Quantitative comparision of the antimicrobial efficiency of leaching versus nonleaching polymer materials. Macromol. Biosci. 2016, 16, 647-654.

[10] Hanna H, et al. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother. 2006 Oct;50(10):3283-8

[11] Yasukawa T, Fujita Y, Sari A. Antimicrobialimpregnated central venous catheters. N Engl J Med. 1999 Jun 3; 340(22):1762

[12] Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology. 1997 Nov; 87(5):1242-4.

[13] Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001; 47: 589-98

[14] Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001; 22: 640-6